Precyte, Inc.

Seattle, WA 98109

SBIR Award Summary

Total Number of Awards 4
Total Value of Awards $2.59MM
Active Awards 1 valued at $299K
First Award Date 09/01/15
Most Recent Award Date 09/15/17

Key Personnel

Last Name Name Awards Contact
SMITH JENNIFER JOY SMITH 4

4 Awards Won

Phase 1 SBIR Active

Agency: Department of Health & Human Services
Topic: PA-16-302
Budget: 09/15/17 - 08/31/18

Project Summary We are developing a novel tool for disease diagnosis called the indicator cell assay platform (iCAP) that uses standardized cultured cells as biosensors to detect disease status of patients from blood or cerebral spinal fluid (CSF) samples. Here, we propose to establish proof of concept for applying the assay to drug discovery by...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAR-14-088
Budget: 06/01/16 - 05/31/17

? DESCRIPTION (provided by applicant): We are developing the Indicator Cell Assay Platform (iCAP), a broadly applicable and inexpensive platform for blood-based diagnostics that can be used for early detection of disease, and as a companion diagnostic for drug development. The iCAP uses cultured cells as biosensors, capitalizing on the ability...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 01/01/16 - 12/31/16

? DESCRIPTION (provided by applicant): We are developing the Indicator Cell Assay Platform (iCAP), a broadly applicable and inexpensive blood- based assay that can be used for early detection of disease, disease stage stratification, prognosis and response to therapeutic intervention for a variety of diseases. The iCAP uses cultured cells as ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAR-14-088
Budget: 09/01/15 - 05/31/16

DESCRIPTION (provided by applicant): We are developing the Indicator Cell Assay Platform (iCAP), a broadly applicable and inexpensive platform for blood-based diagnostics that can be used for early detection of disease, and as a companion diagnostic for drug development. The iCAP uses cultured cells as biosensors, capitalizing on the ability of ...